Scholars Central

Review articlePublished 2015

Metabolic Syndrome

Authors: Mukund R Mogarekar, Mohit V Rojekar, Swati D Sawant

Journal of Cell Science & Therapy

Volume 6 · Issue 1 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The metabolic syndrome (MetS) is a constellation of interrelated risk factors of metabolic origin - metabolic risk factors - that appear to directly promote the development of atherosclerotic cardiovascular disease (CVDs). It consists of atherogenic dyslipidemia (elevated triglycerides and apolipoprotein B-containing lipoproteins and decreased high-density lipoproteins [HDL]), elevations of blood pressure (BP) and glucose, and prothrombotic and proinflammatory states. The review focuses on epidemiology, pathophysiology of the MetS. Metabolic syndrome is discussed with respect to developmental (childhood and infancy) aspects, genomics and mechanisms of carcinogenesis.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Mukund R Mogarekar”
  • BylineArticles whose byline prints “Mohit V Rojekar”
  • BylineArticles whose byline prints “Swati D Sawant”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels